Brussels Region (BE1)


The region has a population of 1.2 million. In terms of health, the region's strengths lie in its large hospital-hospital hub and the high concentration of people with varied socio-cultural profiles. This provides a breeding ground for clinical trials and collaborations between different scientific disciplines (engineering sciences, life sciences, etc.).


Medical research in the region is recognized in oncology, chronic and neurodegenerative diseases, medical devices and medical engineering. The objective of the strategic field of activity "Personalized Medicine and Wellness" is therefore to capitalize on these assets in order to improve the performance of care and the quality of life of patients. There is a focus on the development of personalized therapies and services, improving the hospital-to-home care chain (e-health) and prevention, by improving the environmental quality of life.

Regional website

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

Major initiatives

  1. Bridge program on personalised medicine

  2. Join R&D Call Predictive Medicine

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?

Region represented in : EUREKA/Eurostars/COSME

If you would like to add your region to the Observatory please complete the survey here

Image attribution


This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium